Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics. / Peiffer, Lukas; Gambichler, Thilo; Buus, Terkild B.; Horny, Kai; Gravemeyer, Jan; Furtmann, Frauke; Spassova, Ivelina; Kubat, Linda; Susok, Laura; Stranzenbach, René; Srinivas, Nalini; Ødum, Niels; Becker, Jürgen C.

In: Frontiers in Oncology, Vol. 13, 1090592, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Peiffer, L, Gambichler, T, Buus, TB, Horny, K, Gravemeyer, J, Furtmann, F, Spassova, I, Kubat, L, Susok, L, Stranzenbach, R, Srinivas, N, Ødum, N & Becker, JC 2023, 'Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics', Frontiers in Oncology, vol. 13, 1090592. https://doi.org/10.3389/fonc.2023.1090592

APA

Peiffer, L., Gambichler, T., Buus, T. B., Horny, K., Gravemeyer, J., Furtmann, F., Spassova, I., Kubat, L., Susok, L., Stranzenbach, R., Srinivas, N., Ødum, N., & Becker, J. C. (2023). Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics. Frontiers in Oncology, 13, [1090592]. https://doi.org/10.3389/fonc.2023.1090592

Vancouver

Peiffer L, Gambichler T, Buus TB, Horny K, Gravemeyer J, Furtmann F et al. Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics. Frontiers in Oncology. 2023;13. 1090592. https://doi.org/10.3389/fonc.2023.1090592

Author

Peiffer, Lukas ; Gambichler, Thilo ; Buus, Terkild B. ; Horny, Kai ; Gravemeyer, Jan ; Furtmann, Frauke ; Spassova, Ivelina ; Kubat, Linda ; Susok, Laura ; Stranzenbach, René ; Srinivas, Nalini ; Ødum, Niels ; Becker, Jürgen C. / Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics. In: Frontiers in Oncology. 2023 ; Vol. 13.

Bibtex

@article{6190b47a2e8044468a192a8ac2219336,
title = "Phenotypic plasticity of malignant T cells in blood and skin of a S{\'e}zary syndrome patient revealed by single cell transcriptomics",
abstract = "Background: S{\'e}zary Syndrome (SS) is an aggressive leukemic variant of cutaneous T-cell lymphomas (CTCL). In SS patients, malignant T cells are circulating through the blood and cause erythroderma. Objective: To compare the transcriptome of single cells in blood and skin samples from a patient with advanced SS. Methods: We utilized combined single cell RNA and T-cell receptor (TCR) sequencing (scRNA-seq). Results: We scrutinized the malignant T cells in blood and skin in an unbiased manner without pre-sorting of cells. We observed different phenotypes of the same monoclonal malignant T-cell population, confirmed by TCR sequencing and inferred copy number variation analysis. Malignant T cells present in the circulating blood expressed genes resembling central memory T cells such as CCR7, IL7R and CD27. In the skin, we detected two major malignant T-cell populations: One subpopulation was closely related to the malignant T cells from the blood, while the other subpopulation expressed genes reminiscent of skin resident effector memory T cells including GZMB and NKG7. Pseudotime analysis indicated crucial transcriptomic changes in the transition of malignant T cells between blood and skin. These changes included the differential regulation of TXNIP, a putative tumor suppressor in CTCL, and the adaptation to the hypoxic conditions in the skin. Tumor cell proliferation in the skin was supported by stimulating interactions between myeloid cells and malignant T cells. Conclusions: Using scRNA-seq we detected a high degree of functional heterogeneity within the malignant T-cell population in SS and highlighted crucial differences between SS cells in blood and skin.",
keywords = "cutaneous T cell lymphoma, inflammation, malignant T cells, reactive T cells, scRNAseq, S{\'e}zary syndrome",
author = "Lukas Peiffer and Thilo Gambichler and Buus, {Terkild B.} and Kai Horny and Jan Gravemeyer and Frauke Furtmann and Ivelina Spassova and Linda Kubat and Laura Susok and Ren{\'e} Stranzenbach and Nalini Srinivas and Niels {\O}dum and Becker, {J{\"u}rgen C.}",
note = "Publisher Copyright: Copyright {\textcopyright} 2023 Peiffer, Gambichler, Buus, Horny, Gravemeyer, Furtmann, Spassova, Kubat, Susok, Stranzenbach, Srinivas, {\O}dum and Becker.",
year = "2023",
doi = "10.3389/fonc.2023.1090592",
language = "English",
volume = "13",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S.A.",

}

RIS

TY - JOUR

T1 - Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics

AU - Peiffer, Lukas

AU - Gambichler, Thilo

AU - Buus, Terkild B.

AU - Horny, Kai

AU - Gravemeyer, Jan

AU - Furtmann, Frauke

AU - Spassova, Ivelina

AU - Kubat, Linda

AU - Susok, Laura

AU - Stranzenbach, René

AU - Srinivas, Nalini

AU - Ødum, Niels

AU - Becker, Jürgen C.

N1 - Publisher Copyright: Copyright © 2023 Peiffer, Gambichler, Buus, Horny, Gravemeyer, Furtmann, Spassova, Kubat, Susok, Stranzenbach, Srinivas, Ødum and Becker.

PY - 2023

Y1 - 2023

N2 - Background: Sézary Syndrome (SS) is an aggressive leukemic variant of cutaneous T-cell lymphomas (CTCL). In SS patients, malignant T cells are circulating through the blood and cause erythroderma. Objective: To compare the transcriptome of single cells in blood and skin samples from a patient with advanced SS. Methods: We utilized combined single cell RNA and T-cell receptor (TCR) sequencing (scRNA-seq). Results: We scrutinized the malignant T cells in blood and skin in an unbiased manner without pre-sorting of cells. We observed different phenotypes of the same monoclonal malignant T-cell population, confirmed by TCR sequencing and inferred copy number variation analysis. Malignant T cells present in the circulating blood expressed genes resembling central memory T cells such as CCR7, IL7R and CD27. In the skin, we detected two major malignant T-cell populations: One subpopulation was closely related to the malignant T cells from the blood, while the other subpopulation expressed genes reminiscent of skin resident effector memory T cells including GZMB and NKG7. Pseudotime analysis indicated crucial transcriptomic changes in the transition of malignant T cells between blood and skin. These changes included the differential regulation of TXNIP, a putative tumor suppressor in CTCL, and the adaptation to the hypoxic conditions in the skin. Tumor cell proliferation in the skin was supported by stimulating interactions between myeloid cells and malignant T cells. Conclusions: Using scRNA-seq we detected a high degree of functional heterogeneity within the malignant T-cell population in SS and highlighted crucial differences between SS cells in blood and skin.

AB - Background: Sézary Syndrome (SS) is an aggressive leukemic variant of cutaneous T-cell lymphomas (CTCL). In SS patients, malignant T cells are circulating through the blood and cause erythroderma. Objective: To compare the transcriptome of single cells in blood and skin samples from a patient with advanced SS. Methods: We utilized combined single cell RNA and T-cell receptor (TCR) sequencing (scRNA-seq). Results: We scrutinized the malignant T cells in blood and skin in an unbiased manner without pre-sorting of cells. We observed different phenotypes of the same monoclonal malignant T-cell population, confirmed by TCR sequencing and inferred copy number variation analysis. Malignant T cells present in the circulating blood expressed genes resembling central memory T cells such as CCR7, IL7R and CD27. In the skin, we detected two major malignant T-cell populations: One subpopulation was closely related to the malignant T cells from the blood, while the other subpopulation expressed genes reminiscent of skin resident effector memory T cells including GZMB and NKG7. Pseudotime analysis indicated crucial transcriptomic changes in the transition of malignant T cells between blood and skin. These changes included the differential regulation of TXNIP, a putative tumor suppressor in CTCL, and the adaptation to the hypoxic conditions in the skin. Tumor cell proliferation in the skin was supported by stimulating interactions between myeloid cells and malignant T cells. Conclusions: Using scRNA-seq we detected a high degree of functional heterogeneity within the malignant T-cell population in SS and highlighted crucial differences between SS cells in blood and skin.

KW - cutaneous T cell lymphoma

KW - inflammation

KW - malignant T cells

KW - reactive T cells

KW - scRNAseq

KW - Sézary syndrome

U2 - 10.3389/fonc.2023.1090592

DO - 10.3389/fonc.2023.1090592

M3 - Journal article

C2 - 36761972

AN - SCOPUS:85147676108

VL - 13

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

M1 - 1090592

ER -

ID: 340113202